Pathology of Nonalcoholic Fatty Liver Disease-Reference-Cited by-同舟云学术

Pathology of Nonalcoholic Fatty Liver Disease

Published:2007-11 Issue:5 Volume:128 Page:837-847
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:Am J Clin Pathol

Author:

Yeh Matthew M.,Brunt Elizabeth M.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/128/5/837/4988959/ajcpath128-0837.pdf

Reference92 articles.

1. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology. 2003; 37:1202-1219.

2. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006; 43(2 suppl 1):S99-S112.

3. Farrell GC. Non-alcoholic steatohepatitiś: what is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol. 2003; 18:124-138.

4. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology. 2002; 122:1649-1657.

5. Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology. 2005; 42:987-1000.

Cited by 260 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-encapsulation of Lactobacillus plantarum and EGCG: A promising strategy to increase the stability and lipid-lowering activity;Food Hydrocolloids;2024-06

2. Portal hypertension in patients with nonalcoholic fatty liver disease: Current knowledge and challenges;World Journal of Gastroenterology;2024-01-28

3. Non-Neoplastic Disorders of the Liver;Gastrointestinal and Liver Pathology;2024

4. Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis;Scientific Reports;2023-12-27

5. Accumulation of α-synuclein in hepatocytes in nonalcoholic steatohepatitis and its usefulness in pathological diagnosis;Pathology - Research and Practice;2023-07